Bromelain treatment decreases neutrophil migration to sites of inflammation
- 14 May 2008
- journal article
- Published by Elsevier BV in Clinical Immunology
- Vol. 128 (1), 66-74
- https://doi.org/10.1016/j.clim.2008.02.015
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Center for Complementary and Alternative Medicine
This publication has 33 references indexed in Scilit:
- Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitroClinical Immunology, 2007
- Bromelain exerts anti-inflammatory effects in an ovalbumin-induced murine model of allergic airway diseaseCellular Immunology, 2005
- Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel diseaseClinical Immunology, 2005
- Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee ? a double-blind prospective randomized studyClinical Rheumatology, 2004
- Proteolytic Inhibition ofSalmonella entericaSerovar Typhimurium-Induced Activation of the Mitogen-Activated Protein Kinases ERK and JNK in Cultured Human Intestinal CellsInfection and Immunity, 2002
- Bromelain Modulates T Cell and B Cell Immune Responses in Vitro and in VivoCellular Immunology, 2001
- Bromelain Activates Murine Macrophages and Natural Killer Cells in VitroCellular Immunology, 2001
- Ratio of Local to Systemic Chemokine Concentrations Regulates Neutrophil RecruitmentThe American Journal of Pathology, 2001
- Prevention of Murine EAE by Oral Hydrolytic Enzyme TreatmentJournal of Autoimmunity, 1999
- Effects of an orally active non‐peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin‐induced pleurisyBritish Journal of Pharmacology, 1997